Your session is about to expire
← Back to Search
Progesterone 200 mg capsules for Nicotine Addiction
Phase 4
Waitlist Available
Led By Cynthia N Epperson, M.D.
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up test day #2 and test day #5 - 6 total scans over the period of 2-3 months.
Awards & highlights
Study Summary
This trial recruited male and female smokers and had them undergo two 4-day phases of smoking cessation. Each phase involved 3 brain-imaging scans, blood draws, and an intervention involving either progesterone or a placebo.
Eligible Conditions
- Nicotine Addiction
- Nicotine Withdrawal
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ test day #2 and test day #5 - 6 total scans over the period of 2-3 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~test day #2 and test day #5 - 6 total scans over the period of 2-3 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
GABA Pre and Post Progesterone Administration (Dorsal Anterior Cingulate Cortex [DACC])
GABA Pre and Post Progesterone Administration (Dorsolateral Pre-Frontal Cortex [DLPFC])
Secondary outcome measures
Brief Questionnaire on Smoking Urges (BQSU)
Nicotine Effects Questionnaire (NEQ) Question: Feels Bad Effects of Nicotine
Nicotine Effects Questionnaire (NEQ) Question: Feels Good Effects of Nicotine
+28 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Progesterone 200 mg capsulesActive Control1 Intervention
Subjects will be prescribed progesterone 200 mg capsules by the study Principal Investigator. Subjects will take 200 mg of progesterone daily for four days.
Group II: Progesterone 200 mg look-alike capsulesPlacebo Group1 Intervention
Subjects will be prescribed progesterone 200 mg look-alike placebo capsules by the study Principal Investigator. Subjects will take look-alike placebo capsules daily for four days.
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,512 Total Patients Enrolled
15 Trials studying Nicotine Addiction
2,130 Patients Enrolled for Nicotine Addiction
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,799 Total Patients Enrolled
8 Trials studying Nicotine Addiction
1,955 Patients Enrolled for Nicotine Addiction
Cynthia N Epperson, M.D.Principal InvestigatorAssociate Professor of Psychiatry, University of Pennsylvania
3 Previous Clinical Trials
1,582 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger